Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Debt Ratio (2016 - 2022)

Historic Debt Ratio for Avadel Pharmaceuticals (AVDL) over the last 14 years, with Q3 2022 value amounting to 0.93.

  • Avadel Pharmaceuticals' Debt Ratio rose 7371.96% to 0.93 in Q3 2022 from the same period last year, while for Sep 2022 it was 0.93, marking a year-over-year increase of 7371.96%. This contributed to the annual value of 0.58 for FY2021, which is 3997.98% up from last year.
  • Latest data reveals that Avadel Pharmaceuticals reported Debt Ratio of 0.93 as of Q3 2022, which was up 7371.96% from 0.85 recorded in Q2 2022.
  • Avadel Pharmaceuticals' Debt Ratio's 5-year high stood at 0.93 during Q3 2022, with a 5-year trough of 0.01 in Q2 2020.
  • For the 5-year period, Avadel Pharmaceuticals' Debt Ratio averaged around 0.47, with its median value being 0.48 (2021).
  • In the last 5 years, Avadel Pharmaceuticals' Debt Ratio crashed by 9616.85% in 2020 and then skyrocketed by 884872.42% in 2021.
  • Avadel Pharmaceuticals' Debt Ratio (Quarter) stood at 0.66 in 2018, then grew by 27.74% to 0.84 in 2019, then plummeted by 51.04% to 0.41 in 2020, then skyrocketed by 39.98% to 0.58 in 2021, then skyrocketed by 62.3% to 0.93 in 2022.
  • Its Debt Ratio was 0.93 in Q3 2022, compared to 0.85 in Q2 2022 and 0.65 in Q1 2022.